{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T10:18:53Z","timestamp":1778494733624,"version":"3.51.4"},"reference-count":39,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The parathyroid hormone receptor-1 (PTHR1) plays critical roles in regulating blood calcium levels and bone metabolism and is thus of interest for small-molecule ligand development. Of the few small-molecule ligands reported for the PTHR1, most are of low affinity, and none has a well-defined mechanism of action. Here, we show that SW106 and AH-3960, compounds previously identified to act as an antagonist and agonist, respectively, on the PTHR1, each bind to PTHR1-delNT, a PTHR1 construct that lacks the large amino-terminal extracellular domain used for binding endogenous PTH peptide ligands, with the same micromolar affinity with which it binds to the intact PTHR1. SW106 antagonized PTHR1-mediated cAMP signaling induced by the peptide analog, M-PTH(1\u201311), as well as by the native PTH(1\u20139) sequence, as tethered to the extracellular end of transmembrane domain (TMD) helix-1 of the receptor. SW106, however, did not function as an inverse agonist on either PTHR1-H223R or PTHR1-T410P, which have activating mutations at the cytoplasmic ends of TMD helices 2 and 6, respectively. The overall data indicate that SW106 and AH-3960 each bind to the PTHR1 TMD region and likely to within an extracellularly exposed area that is occupied by the N-terminal residues of PTH peptides. Additionally, they suggest that the inhibitory effects of SW106 are limited to the extracellular portions of the TMD region that mediate interactions with agonist ligands but do not extend to receptor-activation determinants situated more deeply in the helical bundle. The study helps to elucidate potential mechanisms of small-molecule binding at the PTHR1.<\/jats:p>","DOI":"10.1210\/me.2014-1129","type":"journal-article","created":{"date-parts":[[2015,1,13]],"date-time":"2015-01-13T17:30:14Z","timestamp":1421170214000},"page":"307-321","source":"Crossref","is-referenced-by-count":33,"title":["Actions of the Small Molecule Ligands SW106 and AH-3960 on the Type-1 Parathyroid Hormone Receptor"],"prefix":"10.1210","volume":"29","author":[{"given":"Percy H.","family":"Carter","sequence":"first","affiliation":[{"name":"Endocrine Unit (T.D., A.K., T.J.G.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02492"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Dean","sequence":"additional","affiliation":[{"name":"Endocrine Unit (T.D., A.K., T.J.G.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02492"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brijesh","family":"Bhayana","sequence":"additional","affiliation":[{"name":"Department of Photomedicine (B.B.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02492"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashok","family":"Khatri","sequence":"additional","affiliation":[{"name":"Endocrine Unit (T.D., A.K., T.J.G.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02492"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raj","family":"Rajur","sequence":"additional","affiliation":[{"name":"CreaGen Biosciences, Inc (R.R.), Woburn, Massachusetts 01801; and Bristol-Myers Squibb Co (P.H.C.), Princeton, New Jersey 08543"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Gardella","sequence":"additional","affiliation":[{"name":"Endocrine Unit (T.D., A.K., T.J.G.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02492"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071614001312800_B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1346.002","article-title":"PTHrP and skeletal development","volume":"1068","author":"Kronenberg","year":"2006","journal-title":"Ann NY Acad Sci"},{"issue":"1","key":"2020071614001312800_B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tips.2013.11.001","article-title":"Insights into the structure of class B GPCRs","volume":"35","author":"Hollenstein","year":"2014","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"2020071614001312800_B3","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2174\/157015907781695928","article-title":"Allosteric modulators of class B G-protein-coupled receptors","volume":"5","author":"Hoare","year":"2007","journal-title":"Curr Neuropharmacol"},{"issue":"13","key":"2020071614001312800_B4","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1073\/pnas.0801027105","article-title":"Molecular recognition of parathyroid hormone by its G protein-coupled receptor","volume":"105","author":"Pioszak","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"41","key":"2020071614001312800_B5","doi-asserted-by":"crossref","first-page":"28382","DOI":"10.1074\/jbc.M109.022905","article-title":"Structural basis for parathyroid hormone-related protein binding to the parathyroid hormone receptor and design of conformation-selective peptides","volume":"284","author":"Pioszak","year":"2009","journal-title":"J Biol Chem"},{"issue":"7","key":"2020071614001312800_B6","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1021\/bi051833a","article-title":"The mid-region of parathyroid hormone (1\u201334) serves as a functional docking domain in receptor activation","volume":"45","author":"Wittelsberger","year":"2006","journal-title":"Biochemistry"},{"issue":"41","key":"2020071614001312800_B7","doi-asserted-by":"crossref","first-page":"38524","DOI":"10.1074\/jbc.M202544200","article-title":"Selective ligand-induced stabilization of active and desensitized parathyroid hormone type 1 receptor conformations","volume":"277","author":"Bisello","year":"2002","journal-title":"J Biol Chem"},{"issue":"3","key":"2020071614001312800_B8","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.bbrc.2004.11.069","article-title":"Parathyroid hormone and parathyroid hormone-related peptide, and their receptors","volume":"328","author":"Gensure","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"7459","key":"2020071614001312800_B9","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nature12393","article-title":"Structure of the human glucagon class B G-protein-coupled receptor","volume":"499","author":"Siu","year":"2013","journal-title":"Nature"},{"issue":"7459","key":"2020071614001312800_B10","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nature12357","article-title":"Structure of class B GPCR corticotropin-releasing factor receptor 1","volume":"499","author":"Hollenstein","year":"2013","journal-title":"Nature"},{"issue":"13","key":"2020071614001312800_B11","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1111\/bph.12689","article-title":"Structure of Class B GPCRs: new horizons for drug discovery","volume":"171","author":"Bortolato","year":"2014","journal-title":"Br J Pharmacol"},{"key":"2020071614001312800_B12","doi-asserted-by":"crossref","first-page":"49003","DOI":"10.1074\/jbc.M106827200","article-title":"Parathyroid hormone-(1\u201314) and -(1\u201311) analogs conformationally constrained by \u03b1-aminoisobutyric acid mediate full agonist responses via the juxtamembrane region of the PTH-1 receptor","volume":"276","author":"Shimizu","year":"2001","journal-title":"J Biol Chem"},{"key":"2020071614001312800_B13","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1359\/jbmr.040914","article-title":"Amino-terminal parathyroid hormone fragment analogs containing \u03b1,\u03b1-di-alkyl amino acids at positions 1 and 3","volume":"19","author":"Shimizu","year":"2004","journal-title":"J Bone Miner Res"},{"key":"2020071614001312800_B14","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1210\/endo-123-5-2597","article-title":"A new highly potent parathyroid hormone antagonist: [D-Trp12,Tyr34]bPTH-(7\u201334)NH2","volume":"123","author":"Goldman","year":"1988","journal-title":"Endocrinology"},{"key":"2020071614001312800_B15","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1210\/endo.140.11.7102","article-title":"Studies of the N-terminal region of a parathyroid hormone-related peptide (1\u201336) analog: receptor subtype-selective agonists, antagonists and photochemical cross-linking agents","volume":"140","author":"Carter","year":"1999","journal-title":"Endocrinology"},{"issue":"1","key":"2020071614001312800_B16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1074\/jbc.275.1.9","article-title":"Photoaffinity cross-linking identifies differences in the interactions of an agonist and an antagonist with the parathyroid hormone\/parathyroid hormone-related protein receptor","volume":"275","author":"Behar","year":"2000","journal-title":"J Biol Chem"},{"issue":"3","key":"2020071614001312800_B17","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1074\/jbc.M408270200","article-title":"Novel parathyroid hormone (PTH) antagonists that bind to the juxtamembrane portion of the PTH\/PTH-related protein receptor","volume":"280","author":"Shimizu","year":"2005","journal-title":"J Biol Chem"},{"issue":"4","key":"2020071614001312800_B18","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1210\/endo.142.4.8103","article-title":"Selective and nonselective inverse agonists for constitutively active type-1 parathyroid hormone receptors: evidence for altered receptor conformations","volume":"142","author":"Carter","year":"2001","journal-title":"Endocrinology"},{"key":"2020071614001312800_B19","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1056\/NEJM199609053351004","article-title":"Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia","volume":"335","author":"Schipani","year":"1996","journal-title":"New Eng J Med"},{"issue":"2","key":"2020071614001312800_B20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1210\/jc.2011-2332","article-title":"Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives","volume":"97","author":"Baron","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2020071614001312800_B21","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-8587(13)70106-2","article-title":"Efficacy and safety of recombinant human parathyroid hormone (1\u201384) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study","volume":"1","author":"Mannstadt","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"2020071614001312800_B22","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.bone.2006.06.010","article-title":"Intermittent treatment with parathyroid hormone (PTH) as well as a non-peptide small molecule agonist of the PTH1 receptor inhibits adipocyte differentiation in human bone marrow stromal cells","volume":"39","author":"Rickard","year":"2006","journal-title":"Bone"},{"issue":"20","key":"2020071614001312800_B23","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1021\/jm0707626","article-title":"Discovery and characterization of novel, potent, non-peptide parathyroid hormone-1 receptor antagonists","volume":"50","author":"McDonald","year":"2007","journal-title":"J Med Chem"},{"issue":"16","key":"2020071614001312800_B24","doi-asserted-by":"crossref","first-page":"6846","DOI":"10.1073\/pnas.0605125104","article-title":"Discovery of a small molecule antagonist of the parathyroid hormone receptor by using an N-terminal parathyroid hormone peptide probe","volume":"104","author":"Carter","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"2020071614001312800_B25","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0960-894X(01)00239-6","article-title":"4,1-Benzoxazepinone analogues of efavirenz (Sustiva) as HIV-1 reverse transcriptase inhibitors","volume":"11","author":"Cocuzza","year":"2001","journal-title":"Bioorg Med Chem Lett"},{"key":"2020071614001312800_B26","article-title":"PTH Agonists","author":"Cowan","year":"2005"},{"issue":"11","key":"2020071614001312800_B27","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1021\/cb200248h","article-title":"A luminescent biosensor with increased dynamic range for intracellular cAMP","volume":"6","author":"Binkowski","year":"2011","journal-title":"ACS Chem Biol"},{"key":"2020071614001312800_B28","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1210\/me.2005-0349","article-title":"Mechanisms of ligand binding to the PTH\/PTHrp receptor: selectivity of a modified PTH(1\u201315) radioligand for G\u03b1S-coupled receptor conformations","volume":"20","author":"Dean","year":"2006","journal-title":"Mol Endocrinol"},{"issue":"3","key":"2020071614001312800_B29","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0022-3565(24)38276-X","article-title":"Measurement of agonist and antagonist ligand-binding parameters at the human parathyroid hormone type 1 receptor: evaluation of receptor states and modulation by guanine nucleotide","volume":"289","author":"Hoare","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"issue":"35","key":"2020071614001312800_B30","doi-asserted-by":"crossref","first-page":"27274","DOI":"10.1016\/S0021-9258(19)61507-3","article-title":"Molecular determinants of tuberoinfundibular peptide of 39 residues (TIP39) selectivity for the parathyroid hormone-2 (PTH2) receptor. N-terminal truncation of TIP39 reverses PTH2 receptor\/PTH1 receptor binding selectivity","volume":"275","author":"Hoare","year":"2000","journal-title":"J Biol Chem"},{"key":"2020071614001312800_B31","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1210\/endo.137.9.8756569","article-title":"Inverse agonism of amino-terminally truncated parathyroid hormone (PTH) and PTH-related peptide (PTHrP) analogs revealed with constitutively active mutant PTH\/PTHrP receptors","volume":"137","author":"Gardella","year":"1996","journal-title":"Endocrinology"},{"issue":"23","key":"2020071614001312800_B32","doi-asserted-by":"crossref","first-page":"14146","DOI":"10.1074\/jbc.273.23.14146","article-title":"Minor modifications of a cholecystokinin-B\/gastrin receptor non-peptide antagonist confer a broad spectrum of functional properties","volume":"273","author":"Beinborn","year":"1998","journal-title":"J Biol Chem"},{"issue":"26","key":"2020071614001312800_B33","doi-asserted-by":"crossref","first-page":"19456","DOI":"10.1074\/jbc.M001596200","article-title":"Autoactivation of type-1 parathyroid hormone receptors containing a tethered ligand","volume":"275","author":"Shimizu","year":"2000","journal-title":"J Biol Chem"},{"issue":"2","key":"2020071614001312800_B34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0301-4622(02)00005-4","article-title":"Molecular characterization of a ligand-tethered parathyroid hormone receptor","volume":"95","author":"Monticelli","year":"2002","journal-title":"Biophys Chem"},{"issue":"3","key":"2020071614001312800_B35","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1124\/mol.63.3.751","article-title":"Mechanism of corticotropin-releasing factor type I receptor regulation by nonpeptide antagonists","volume":"63","author":"Hoare","year":"2003","journal-title":"Mol Pharmacol"},{"key":"2020071614001312800_B36","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1016\/S0021-9258(20)79672-9","article-title":"A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled \u03b2-adrenergic receptor","volume":"255","author":"De Lean","year":"1980","journal-title":"J Biol Chem"},{"issue":"11","key":"2020071614001312800_B37","doi-asserted-by":"crossref","first-page":"7741","DOI":"10.1074\/jbc.M009395200","article-title":"Evaluating the signal transduction mechanism of the parathyroid hormone 1 receptor. Effect of receptor-G-protein interaction on the ligand binding mechanism and receptor conformation","volume":"276","author":"Hoare","year":"2001","journal-title":"J Biol Chem"},{"issue":"12","key":"2020071614001312800_B38","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.2337\/db10-0689","article-title":"Novel small molecule glucagon-like peptide-1 receptor agonist stimulates insulin secretion in rodents and from human islets","volume":"59","author":"Sloop","year":"2010","journal-title":"Diabetes"},{"issue":"13","key":"2020071614001312800_B39","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1021\/bi036110a","article-title":"Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists","volume":"43","author":"Hoare","year":"2004","journal-title":"Biochemistry"}],"container-title":["Molecular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mend\/article-pdf\/29\/2\/307\/8913713\/mend0307.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/mend\/article-pdf\/29\/2\/307\/8913713\/mend0307.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T20:18:53Z","timestamp":1747426733000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mend\/article\/29\/2\/307\/2556461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,1]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/me.2014-1129","relation":{},"ISSN":["0888-8809","1944-9917"],"issn-type":[{"value":"0888-8809","type":"print"},{"value":"1944-9917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,1]]}}}